• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有脑脊液阿尔茨海默病特征的患者的初始记忆缺陷概况。

Initial memory deficit profiles in patients with a cerebrospinal fluid Alzheimer's disease signature.

作者信息

Xie Jing, Gabelle Audrey, Dorey Aline, Garnier-Crussard Antoine, Perret-Liaudet Armand, Delphin-Combe Floriane, Bathsavanis Anthony, Dauphinot Virginie, Lehmann Sylvain, Mercier Bernadette, Desestret Virginie, Roullet-Solignac Isabelle, Vighetto Alain, Krolak-Salmon Pierre

机构信息

Research and Resources Memory Center of Lyon, Hôpital des Charpennes, Hospices Civils de Lyon, Lyon, France.

Research and Resources Memory Center of Montpellier, University Hospital of Montpellier, and INSERM U1040, Institute of Biotherapies, France.

出版信息

J Alzheimers Dis. 2014;41(4):1109-16. doi: 10.3233/JAD-131916.

DOI:10.3233/JAD-131916
PMID:24762946
Abstract

BACKGROUND

Alzheimer's disease (AD) clinical onset is usually characterized by a memory complaint and a progressive memory deficit. The proportion of typical medial-temporal amnesia revealing AD remains unknown.

OBJECTIVE

The present study explores the episodic memory impairment profiles by the Free and Cued Selective Recall Reminding Test (FCSRT) in patients with initial memory complaint and a cerebrospinal fluid (CSF) biomarker signature of AD.

METHODS

Seventy-three patients referred for memory complaint to the Centers for Memory, Resource and Research of Lyon and Montpellier (France) were included consecutively. All patients underwent an extensive neuropsychological examination and had a Mini-Mental State Examination (MMSE) score ≥20 and a positive CSF AD signature. The patients were classified as having mild dementia or prodromal AD. Verbal episodic memory was assessed using the French version of the FCSRT exploring encoding, storage/consolidation, and cued delayed retrieval phases of memorization. Three different memory profiles were identified according to the results of FCSRT.

RESULTS

The median age was 72 year-old [interquartiles: 65-76]. The median MMSE score was 23 [interquartiles: 21-25]. 88% of the patients (n = 64) presented with a medial temporal amnesia profile. The dysexecutive amnesia and normal verbal episodic memory profiles represented respectively 5% (n = 4) and 7% (n = 5). There were no significant differences in term of age, gender, and MMSE score between the three profile groups.

CONCLUSION

In a population initially presenting with memory complaints and depicting a CSF AD signature, a high proportion of medial temporal amnesia is disclosed as expected, but also a proportion of dysexecutive amnesia and normal FCSRT.

摘要

背景

阿尔茨海默病(AD)的临床起病通常以记忆主诉和进行性记忆缺陷为特征。典型的内侧颞叶失忆症在AD中所占比例尚不清楚。

目的

本研究通过自由和线索选择性回忆提醒测试(FCSRT),探索初始有记忆主诉且脑脊液(CSF)生物标志物呈AD特征的患者的情景记忆障碍模式。

方法

连续纳入73名因记忆主诉转诊至法国里昂和蒙彼利埃记忆、资源与研究中心的患者。所有患者均接受了全面的神经心理学检查,简易精神状态检查表(MMSE)评分≥20,且脑脊液AD特征呈阳性。这些患者被分为轻度痴呆或前驱性AD。使用FCSRT的法语版本评估言语情景记忆,该测试探索记忆的编码、存储/巩固以及线索延迟检索阶段。根据FCSRT的结果确定了三种不同的记忆模式。

结果

中位年龄为72岁[四分位间距:65 - 76岁]。MMSE评分中位数为23[四分位间距:21 - 25]。88%的患者(n = 64)呈现内侧颞叶失忆模式。执行功能障碍性失忆和正常言语情景记忆模式分别占5%(n = 4)和7%(n = 5)。三个模式组在年龄、性别和MMSE评分方面无显著差异。

结论

在最初有记忆主诉且脑脊液呈AD特征的人群中,如预期的那样,发现高比例的内侧颞叶失忆症,但也有一定比例的执行功能障碍性失忆和FCSRT正常者。

相似文献

1
Initial memory deficit profiles in patients with a cerebrospinal fluid Alzheimer's disease signature.具有脑脊液阿尔茨海默病特征的患者的初始记忆缺陷概况。
J Alzheimers Dis. 2014;41(4):1109-16. doi: 10.3233/JAD-131916.
2
Cerebrospinal fluid biomarkers and memory present distinct associations along the continuum from healthy subjects to AD patients.脑脊液生物标志物与记忆在从健康受试者到 AD 患者的连续体上呈现出不同的关联。
J Alzheimers Dis. 2011;23(2):319-26. doi: 10.3233/JAD-2010-101422.
3
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease.在阿尔茨海默病前驱期提示性回忆记忆缺陷的生物标志物验证。
Neurology. 2012 Feb 7;78(6):379-86. doi: 10.1212/WNL.0b013e318245f447. Epub 2012 Jan 11.
4
Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.两种言语记忆测量方法联合应用对阿尔茨海默病所致轻度认知障碍的诊断及预后价值
J Alzheimers Dis. 2017;58(3):909-918. doi: 10.3233/JAD-170073.
5
Associations Between Free and Cued Selective Reminding Test and Cerebrospinal Fluid Biomarkers in Amnestic Mild Cognitive Impairment.遗忘型轻度认知障碍患者自由和线索选择性提醒测试与脑脊液生物标志物之间的关联。
J Alzheimers Dis. 2024;100(2):713-723. doi: 10.3233/JAD-240150.
6
Biomarker profiles and their relation to clinical variables in mild cognitive impairment.轻度认知障碍中的生物标志物特征及其与临床变量的关系。
Neurocase. 2005 Feb;11(1):8-13. doi: 10.1080/13554790490896785.
7
Interactions between amyloid-β and tau in cerebrospinal fluid of people with mild cognitive impairment and Alzheimer's disease.轻度认知障碍和阿尔茨海默病患者脑脊液中β淀粉样蛋白与tau蛋白的相互作用。
J Alzheimers Dis. 2014;42 Suppl 3:S91-8. doi: 10.3233/JAD-132393.
8
In-Out-Test: A New Paradigm for Sorting the Wheat from the Chaff in Prodromal Alzheimer's Disease.内外测试:在前驱期阿尔茨海默病中筛选的新范式。
J Alzheimers Dis. 2019;67(1):265-277. doi: 10.3233/JAD-171007.
9
TMA-93 Validation by Alzheimer's Disease Biomarkers: A Comparison with the Free and Cued Selective Reminding Test on a Biobank Sample.阿尔茨海默病生物标志物验证 TMA-93:与生物库样本中自由和提示选择性回忆测验的比较。
J Alzheimers Dis. 2021;82(1):401-410. doi: 10.3233/JAD-210115.
10
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.DESCRIPA研究中主观认知障碍或轻度认知障碍患者脑脊液阿尔茨海默病病理标志物的患病率及预后价值:一项前瞻性队列研究
Lancet Neurol. 2009 Jul;8(7):619-27. doi: 10.1016/S1474-4422(09)70139-5. Epub 2009 Jun 10.

引用本文的文献

1
A remote digital memory composite to detect cognitive impairment in memory clinic samples in unsupervised settings using mobile devices.一种远程数字记忆合成工具,用于在无监督环境下使用移动设备检测记忆门诊样本中的认知障碍。
NPJ Digit Med. 2024 Mar 26;7(1):79. doi: 10.1038/s41746-024-00999-9.
2
Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.自动化FACEmemory®评分与早发性轻度认知障碍中的阿尔茨海默病表型和生物标志物相关:BIOFACE队列研究
Alzheimers Res Ther. 2022 Mar 18;14(1):43. doi: 10.1186/s13195-022-00988-8.
3
Associations of Stages of Objective Memory Impairment With Amyloid PET and Structural MRI: The A4 Study.
客观记忆障碍分期与淀粉样 PET 和结构 MRI 的相关性:A4 研究。
Neurology. 2022 Mar 29;98(13):e1327-e1336. doi: 10.1212/WNL.0000000000200046. Epub 2022 Feb 23.
4
Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.客观记忆损伤阶段预测阿尔茨海默病神经病理学:与临床痴呆评定量表-框总数的比较。
J Alzheimers Dis. 2021;80(1):185-195. doi: 10.3233/JAD-200946.
5
Temporal unfolding of declining episodic memory on the Free and Cued Selective Reminding Test in the predementia phase of Alzheimer's disease: Implications for clinical trials.阿尔茨海默病痴呆前阶段自由和提示选择性回忆测试中情景记忆衰退的时间演变:对临床试验的启示
Alzheimers Dement (Amst). 2018 Jan 12;10:161-171. doi: 10.1016/j.dadm.2017.12.004. eCollection 2018.
6
Identifying memory impairment and early dementia in primary care.在初级保健中识别记忆障碍和早期痴呆症。
Alzheimers Dement (Amst). 2017 Feb 24;6:188-195. doi: 10.1016/j.dadm.2017.01.006. eCollection 2017.